Location History:
- Guangzhou, CN (2014)
- Guangdong, CN (2016)
Company Filing History:
Years Active: 2014-2016
Title: Inventor Spotlight: Hanfei Sang
Introduction
Hanfei Sang is an innovative inventor based in Guangdong, China, recognized for his significant contributions to the field of neuroprotective drug development. With two patents to his name, Sang is dedicated to advancing medical treatments that protect neurons from injury.
Latest Patents
Hanfei Sang holds two notable patents related to the use of specific compounds in preparing neuroprotective drugs. The first patent is titled "Use of 5α-androstane-3β,5,6β-triol in preparation of neuroprotective drugs." This invention highlights the protective effect of 5α-androstane-3β,5,6β-triol against neuron injuries resulting from cerebral ischemia, spinal cord ischemia, or hypoxia, while demonstrating no significant toxic reactions within effective dosages.
His second patent, "Use of 5α-androstane (alkyl)-3β,5,6β-triol in preparation of neuroprotective drugs," presents similar findings, showcasing the compound's protective effects against neuron injuries caused by the same conditions.
Career Highlights
Hanfei Sang is associated with Guangzhou Cellprotek Pharmaceutical Ltd., where he plays a vital role in the research and development of neuroprotective therapies. His work at the company reflects his commitment to enhancing medical science and provides promising avenues for future drug development.
Collaborations
Throughout his career, Hanfei Sang has collaborated with distinguished colleagues, including Guangmei Yan and Haiyan Hu. These partnerships have likely contributed to his research's depth and efficacy, fostering a collaborative environment aimed at advancement in pharmaceutical sciences.
Conclusion
As an accomplished inventor, Hanfei Sang exemplifies the spirit of innovation in the healthcare sector. His patents not only signify his dedication to developing neuroprotective medications but also highlight the ongoing need for research in neuroscience. Sang's work promises great potential, paving the way for advancements that could significantly benefit patients suffering from neuronal injuries.